Back to libraryProstate Health

Vesilute

Research profile · How we handle evidence

Glu-Asp (ED) dipeptide bioregulator researched for urinary tract and prostate-related tissue support.

Evidence Score

43/100

Preclinical signal

Category

Prostate Health

Therapeutic area

Standard Dose

5-10mg

Daily

Half-life

~8 hr

Plasma elimination

Route

SC

Subcutaneous

Safety Tier

3

Limited data

Overview

Vesilute is typically discussed as a short Khavinson bioregulator (often described as Glu-Asp / ED). It’s usually framed around urinary tract comfort and prostate-related tissue support, with the emphasis on gradual, research-stage exploration rather than a guaranteed outcome.

Mechanism of Action

Vesilute is typically discussed as a short Khavinson bioregulator (often described as Glu-Asp / ED). It’s usually framed around urinary tract comfort and prostate-related tissue support, with the emphasis on gradual, research-stage exploration rather than a guaranteed outcome.

WellnessAnti Aging

pH & Mixing

3.6

Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.

A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.

Benefits

  • Prostate support
  • BPH prevention
  • Urinary flow improvement
  • Prostate health maintenance

Side Effects

  • Generally well-tolerated

Contraindications

No entries listed.

Structure & Sequence

View 3D structure

Verified structure

Vesilute

Sequence illustration backed by PubChem match.

Verified via PubChemMatched by casNumber
C9H14N2O7262.20 DaCAS 3918-84-12 residues
Source: PubChemLookup: 3918-84-1InChIKey FYYSIASRLDJUNP-WHFBIAKZSA-N
Amino Acid Sequence
Glu-Asp (ED)
Molecular Weight
262.20 Da
Chemical Formula
C9H14N2O7
CAS Number
3918-84-1
Reconstituted pH
3.6
InChIKey
FYYSIASRLDJUNP-WHFBIAKZSA-N

Stack & Route Context

Stacks with

  • Prostamax
  • Thymosin Alpha-1

Administration

Subcutaneous

Research Status

Research peptide for prostate health

Approval Status

Preclinical

Sports Legal

Permitted

References

  1. 1

    Vesilute peptide: overview and research framing

    View source
  2. 2

    Vesilute (ED/dipeptide) overview page

    View source
  3. 3

    VESILUT detail (Urinary/bladder framing in product listings)

    View source

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.